As of 3:59pm ET
| +0.42 / +1.22%|
The 7 analysts offering 12-month price forecasts for Five Prime Therapeutics Inc have a median target of 60.00, with a high estimate of 94.00 and a low estimate of 57.00. The median estimate represents a +72.22% increase from the last price of 34.84.
The current consensus among 9 polled investment analysts is to Buy stock in Five Prime Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.